These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 48324)

  • 21. Gamma-interferon inhibits extracellular matrix synthesis and remodeling in collagen lattice cultures of normal and scleroderma skin fibroblasts.
    Gillery P; Serpier H; Polette M; Bellon G; Clavel C; Wegrowski Y; Birembaut P; Kalis B; Cariou R; Maquart FX
    Eur J Cell Biol; 1992 Apr; 57(2):244-53. PubMed ID: 1511700
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Increased retraction of collagen lattices by fibroblasts from patients with scleroderma].
    Gillery P; Maquart FX; Kalis B; Borel JP
    C R Acad Sci III; 1986; 303(3):59-64. PubMed ID: 3093006
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Smooth muscle differentiation in scleroderma fibroblastic cells.
    Sappino AP; Masouyé I; Saurat JH; Gabbiani G
    Am J Pathol; 1990 Sep; 137(3):585-91. PubMed ID: 1698026
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bleomycin-induced scleroderma.
    Finch WR; Rodnan GP; Buckingham RB; Prince RK; Winkelstein A
    J Rheumatol; 1980; 7(5):651-9. PubMed ID: 6160247
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Scleroderma-like remodeling induced by type V collagen.
    Bezerra MC; Teodoro WR; de Oliveira CC; Velosa AP; Ogido LT; Gauditano G; Parra ER; Capelozzi VL; Yoshinari NH
    Arch Dermatol Res; 2006 Jul; 298(2):51-7. PubMed ID: 16710740
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mast cell numbers in diffuse scleroderma.
    Nishioka K; Kobayashi Y; Katayama I; Takijiri C
    Arch Dermatol; 1987 Feb; 123(2):205-8. PubMed ID: 3813593
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased numbers of microchimeric cells of fetal origin are associated with dermal fibrosis in mice following injection of vinyl chloride.
    Christner PJ; Artlett CM; Conway RF; Jiménez SA
    Arthritis Rheum; 2000 Nov; 43(11):2598-605. PubMed ID: 11083286
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Is graft-versus-host disease a reliable model for scleroderma?
    Mekori YA; Claman HN
    Ric Clin Lab; 1986; 16(4):509-13. PubMed ID: 3576048
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Glycosaminoglycans in progressive scleroderma].
    Herrmann K; Schinagl A; Gchinagl G; Haustein UF; Lohrisch I
    Dermatol Monatsschr; 1982 Nov; 168(11):761-5. PubMed ID: 7160507
    [No Abstract]   [Full Text] [Related]  

  • 30. Scleroderma and urinary excretion of acidic glycosaminoglycans.
    Hardy KH; Rosevear JW; Sams WM; Winkelmann RK
    Mayo Clin Proc; 1971 Feb; 46(2):119-27. PubMed ID: 4251060
    [No Abstract]   [Full Text] [Related]  

  • 31. Localized scleroderma (morphoea). Clinical, physiological, biochemical and ultrastructural studies with particular reference to quantitation of scleroderma.
    Serup J
    Acta Derm Venereol Suppl (Stockh); 1986; 122():3-61. PubMed ID: 2939680
    [No Abstract]   [Full Text] [Related]  

  • 32. Silicone does not potentiate development of the scleroderma-like syndrome in tight skin (TSK/+) mice.
    Frondoza C; Jones L; Rose NR; Hatakeyama A; Phelps R; Bona C
    J Autoimmun; 1996 Aug; 9(4):473-83. PubMed ID: 8864822
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The pathophysiology of the fibrosis in scleroderma skin.
    Fleischmajer R; Perlish JS
    Prog Clin Biol Res; 1984; 154():381-404. PubMed ID: 6382305
    [No Abstract]   [Full Text] [Related]  

  • 34. Ultrastructure of cutaneous cellular infiltrates in scleroderma.
    Fleischmajer R; Perlish JS; West WP
    Arch Dermatol; 1977 Dec; 113(12):1661-6. PubMed ID: 202203
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Metabolism of the connective tissue in generalized scleroderma].
    Kucharz EJ; Sierakowski SJ
    Postepy Hig Med Dosw; 1989; 43(1):93-102. PubMed ID: 2697876
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Initial change of glycosaminoglycans in systemic scleroderma.
    Ishikawa H; Horiuchi R
    Dermatologica; 1975; 150(6):334-45. PubMed ID: 127727
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cellular and molecular mechanisms of bleomycin-induced murine scleroderma: current update and future perspective.
    Yamamoto T; Nishioka K
    Exp Dermatol; 2005 Feb; 14(2):81-95. PubMed ID: 15679577
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The bleomycin-induced scleroderma model: what have we learned for scleroderma pathogenesis?
    Yamamoto T
    Arch Dermatol Res; 2006 Feb; 297(8):333-44. PubMed ID: 16402183
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-TGF-beta treatment prevents skin and lung fibrosis in murine sclerodermatous graft-versus-host disease: a model for human scleroderma.
    McCormick LL; Zhang Y; Tootell E; Gilliam AC
    J Immunol; 1999 Nov; 163(10):5693-9. PubMed ID: 10553100
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Connective tissue in skin biopsies from patients suffering systemic sclerosis.
    Quaglino D; Bergamini G; Boraldi F; Manzini E; Davidson JM; Pasquali Ronchetti I
    J Submicrosc Cytol Pathol; 1996 Apr; 28(2):287-96. PubMed ID: 8964053
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.